BOSTON BEER CO INC

SAM
About the company

The Boston Beer Company, Inc. produces and sells alcohol beverages primarily in the United States. Its flagship beer is Samuel Adams Boston Lager. The company offers various beers, hard ciders, spirits based ready to drink beverages, distilled spirits, flavored malt beverages, and hard seltzers under the Samuel Adams, Twisted Tea, Truly, Angry Orchard, Dogfish Head, and Sun Cruiser brand names.

Country: United StatesPrice: $221.82Market Cap: $2.3B

Investment snapshot

18%positive consensus
Scored 1d ago

Positive

3

BUY / PASS

Neutral / negative

3 / 10

NEUTRAL / FAIL

Median fair value

$121.98

-45.0% vs price

Models with upside

1 / 17

Positive margin of safety

Strongest signal

6 of 10 pass — Lynch, Dreman, Pabrai +1 more object

Key risk

Models split on SAM at $221.82 — fair values range $77.25–$556.88

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILFAILFAILFAIL · Rank #702 (Top 22.7%)BUYFAILNEUTRALFAILPASSFAILNEUTRALFAILPASSFAILFAILFAILNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/AN/A
Margin of Safety-69.0%-2.4%N/A-187.1%N/A-109.7%-4.0%-104.4%+60.2%-96.8%-13.1%-166.3%N/AN/AN/AN/AN/A
Financial Basis

TTM ended 2026-09-26 · Balance sheet at 2026-09-26 · Annual history · FY 2025

Latest source filing: 2026-10-22

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-02-24

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-26 · TTM ended 2026-09-26 vs 2025-09-27 · TTM ended 2026-09-26

Latest source filing: 2026-10-22

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-02-24

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-02-24

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-26 · Balance sheet at 2026-09-26 · Market data at 2026-11-01

Latest source filing: 2026-10-22

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025 · TTM ended 2026-09-26 · Balance sheet at 2026-09-26

Latest source filing: 2026-10-22

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-02-24

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-09-26 · Balance sheet at 2026-09-26

Latest source filing: 2026-10-22

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-02-24

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-26 · Balance sheet at 2026-09-26 · Market data at 2026-11-01

Latest source filing: 2026-10-22

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-09-26

Latest source filing: 2026-10-22

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-02-24

Score computed: 2026-11-14

TTM ended 2026-09-26 · Balance sheet at 2026-09-26 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025

Latest source filing: 2026-10-22

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-26

Latest source filing: 2026-10-22

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-26

Latest source filing: 2026-10-22

Score computed: 2026-11-14

TTM ended 2026-09-26 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-10-22

Score computed: 2026-11-14

Where It Passes

  • Cash Flow60% pass✓ 8✗ 4▾

    6 of 10 pass — Lynch, Dreman, Pabrai +1 more object

    Free Cash Flow Proxy$144.3M
    ✓BuffettPositive and growing
    FCF Positive and Growing$185.1M
    ✗LynchPositive and growing
    Operating Cash Flow$270.2M
    ✓PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=22.63%, ROA=9.09%
    ✓PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)9.0x
    ✗Dreman< 8x
    P/E or FCF YieldP/E=22.4x, FCF Yield=9.6%
    ✗PabraiP/E < 15 or FCF Yield > 10%
    FCF Positive14/17 years FCF positive
    ✓MarksPositive FCF in majority of recent years
    (OCF - CapEx) / Market Cap7.6%
    ✓Ackman>= 4%
    Price / FCF per Share11.3x
    ✓Ackman<= 25
    Positive Operating Cash Flow frequency17/17 years positive
    ✓SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures$185.1M
    ✓Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization+8.22%; #971/4519 (top 21.5%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Debt & Leverage58% pass✓ 10✗ 5▾

    7 of 12 pass — Graham, Buffett, Lynch +2 more object

    LT Debt vs Net Current Assets
    ✗GrahamLT Debt <= Net Current Assets
    Debt/Equity & Interest CoverageD/E: 0.00, IC: N/A
    ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
    Total Debt / Equity0
    ✓Lynch< 0.33
    Cash - Long-term Debt
    ✗LynchPositive preferred
    LT Debt / Total Assets Change0.00% -> 0.00%
    ✓PiotroskiDecreased YoY
    Current Assets / Current Liabilities1.13
    ✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)
    Total Debt / Shareholders' Equity0
    ✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00x
    Debt Levels0
    ✓MungerDebt/Equity < 0.5✓AkreDebt/Equity < 0.3
    Interest Coverage & Debt/EBITDAIC=N/A (no interest expense), D/EBITDA=0.0x
    ✓MarksInterest Coverage > 3x; Debt/EBITDA < 4x
    Total Debt / Shareholders Equity0
    ✓Ackman<= 1.0
    Negative debt-to-equity (higher means less debt)-0.0000; #1/4210 (top 0.0%)
    ✓AsnessTop 30% of eligible cross-section

Where It Falls Short

  • Valuation models10% pass✓ 1✗ 9▾

    Models split on SAM at $221.82 — fair values range $77.25–$556.88

    Graham fair value$131.22
    ✗Graham-69.0% margin vs $221.82
    Buffett fair value$216.52
    ✗Buffett-2.4% margin vs $221.82
    Greenblatt fair value$77.25
    ✗Greenblatt-187.1% margin vs $221.82
    Dreman fair value$105.80
    ✗Dreman-109.7% margin vs $221.82
    Munger fair value$213.36
    ✗Munger-4.0% margin vs $221.82
    Pabrai fair value$108.54
    ✗Pabrai-104.4% margin vs $221.82
    Akre fair value$556.88
    ✓Akre+60.2% margin vs $221.82
    Marks fair value$112.74
    ✗Marks-96.8% margin vs $221.82
    Ackman fair value$196.21
    ✗Ackman-13.1% margin vs $221.82
    Templeton fair value$83.31
    ✗Templeton-166.3% margin vs $221.82
  • Profitability13% pass✓ 11✗ 24▾

    14 of 16 flag SAM's profitability — Graham, Buffett, Lynch +11 more

    Positive EPS (10 years)17/18 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)147.9%
    ✓Graham>= 33% growth
    Net Income Positive (10+ years)17/18 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)6.8%
    ✗Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)7.4% (latest)
    ✗BuffettStable or rising over 10 years
    Free Cash Flow Proxy$144.3M
    ✓BuffettPositive and growing
    Earnings Variance (10-yr CoV)0.50
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)P/E 22.4x (growth N/A)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR-8.6%
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    ROE-9.9%
    ✗Lynch> 15%
    EBIT / Enterprise Value7.1%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=7.1%, ROC=27.9%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Net Income / Total Assets9.09%
    ✓PiotroskiROA > 0
    ROA Change YoY4.78% -> 9.09% (delta: +4.31%)
    ✓PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=22.63%, ROA=9.09%
    ✓PiotroskiCFO/Assets > ROA
    Gross Margin Change YoY44.4% -> 48.5%
    ✓PiotroskiImproved YoY
    Pre-Tax Income / Revenue-4.6%
    ✗Dreman>= 8%
    Net Income / Shareholders' Equity-9.9%
    ✗Dreman> 12%
    Margin of SafetyP/E=22.4x, P/B=2.9x
    ✗PabraiP/B < 1.5 or P/E < 15
    Return on Equity8.8% (3-yr avg)
    ✗AkreROE > 20% (3-year avg)
    Discount to Intrinsic Value-109.7% (IV=$105.80 vs Price=$221.82)
    ✗Marks>= 20% below intrinsic value
    Positive Net Income Frequency17/17 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue-5.1%
    ✗Ackman>= 15%
    Net Income / Shareholders Equity-9.9%
    ✗Ackman>= 15%
    5-Year EPS CAGR-8.6% CAGR over 5 years
    ✗Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend5.0% (2023) -> 7.4% (2025)
    ✓TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trendgross margin 42.4% -> 48.5%, operating margin 5.0% -> 7.4%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    Net income / market capitalization-3.24%; #3698/6340 (top 58.3%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Gross profit / total assets+75.61%; #286/3702 (top 7.7%)
    ✓AsnessTop 30% of eligible cross-section
    Net income / positive book equity-9.93%; #3409/5226 (top 65.2%)
    ✗AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA-0.0255; #1713/5884 (top 29.1%)
    ✓AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR-8.6% over 5 years
    ✗Neff7%-20% annualized
    Positive Diluted-EPS Years10/10 years positive
    ✓Schloss>= 70% positive over 5-10 observed years (app rule)
  • Efficiency13% pass✓ 3✗ 8▾

    7 of 8 flag SAM's efficiency — Graham, Buffett, Piotroski +4 more

    Current Ratio1.13
    ✗Graham>= 2.0
    ROIC (3-5 yr avg)9.1%
    ✗Buffett> 10%
    ROIC - WACC-0.9%
    ✗BuffettPositive (WACC = 10%)
    EBIT / (NWC + Net Fixed Assets)27.9%
    ✓Greenblatt> 25%
    Current Ratio Change YoY1.80 -> 1.65
    ✗PiotroskiIncreased YoY
    Revenue / Total Assets Change YoY1.61x -> 1.65x
    ✓PiotroskiImproved YoY
    Current Assets / Current Liabilities1.13
    ✗Dreman> 1.5
    Return on Invested Capital-10.3%
    ✗Munger> 15%
    ROIC (high and growing)FY2023: ROIC=7.3%; FY2024: ROIC=6.5%; FY2025: ROIC=13.5%
    ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
    Reinvestment Rate x ROIC13.5% (RR=100% x ROIC=13.5%)
    ✓AkreReinvestment Rate * ROIC > 10%
    ROIC (5-year)1/5 years above 12% (latest 13.5%)
    ✗SleepROIC > 12% in a majority of years
  • Valuation15% pass✓ 2✗ 26▾

    11 of 13 flag SAM's valuation — Graham, Lynch, Greenblatt +8 more

    Price / 3-yr avg EPS31.4x
    ✗Graham<= 15x
    Price-to-Book Ratio2.9x
    ✗Graham<= 1.5x
    P/E x P/B90.20
    ✗Graham<= 22.5
    Basic earnings-growth PEG (dividends excluded)P/E 22.4x (growth N/A)
    ✗Lynch< 1.0 (ideally < 0.5)
    EBIT / Enterprise Value7.1%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=7.1%, ROC=27.9%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Price / EPS22.4x
    ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price / (CFO / Shares)9.0x
    ✗Dreman< 8x
    Price / Book Value per Share2.9x
    ✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
    Valuation ReasonablenessP/E=22.4x, OE Yield=5.9%
    ✓MungerP/E < 25 or Owner Earnings Yield > 5%
    P/E or FCF YieldP/E=22.4x, FCF Yield=9.6%
    ✗PabraiP/E < 15 or FCF Yield > 10%
    P/B or P/E vs. Historical AverageP/E=22.4x, P/B=2.9x
    ✗MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic Value-109.7% (IV=$105.80 vs Price=$221.82)
    ✗Marks>= 20% below intrinsic value
    Price / FCF per Share11.3x
    ✓Ackman<= 25
    Price vs. Trailing Low137% of trailing low ($162.49)
    ✗Templeton<= 120% of trailing low (certified split-adjusted live window)
    Net income / market capitalization-3.24%; #3698/6340 (top 58.3%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Positive book equity / market capitalization+0.3268; #3577/6449 (top 55.5%)
    ✗AsnessTop 30% of eligible cross-section
    Price / Diluted EPS22.4x
    ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E
    ✗Neff> 0.7 (Neff's published traditional edge)
    Price / Tangible Book Value per Share3.37x
    ✗SchlossP/TBV <= 1.00x (app cutoff)
    Book Value per Share Change-0.7%
    ✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization+0.8475; #1963/5247 (top 37.4%)
    ✗OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization+8.22%; #971/4519 (top 21.5%)
    ✗OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date-13.76%; #3642/6202 (top 58.7%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Verdicts21% pass✓ 3✗ 11▾

    Split decision: 10 FAIL · 3 NEUTRAL · 2 PASS · 1 BUY

    Overall verdict
    ✗GrahamFAIL (2/9)✗BuffettFAIL (1/9)✗LynchFAIL (1/7)✗GreenblattRank #702✓PiotroskiBUY (F-Score 8)✗DremanFAIL (4/11)•MungerNEUTRAL (3/4)✗PabraiFAIL (0/3)✓AkrePASS (3/6)✗MarksFAIL (3/5)•AckmanNEUTRAL (6/9)✗TempletonFAIL (3/8)✓SleepPASS (3/6)✗AsnessFAIL (Rank #892/2370 (Top 37.6%))✗NeffFAIL (2/6)✗SchlossFAIL (2/7)•OshaughnessyNEUTRAL (Not ranked)
  • Growth38% pass✓ 5✗ 8▾

    5 of 8 flag SAM's growth — Lynch, Ackman, Templeton +2 more

    EPS Growth (3-yr avg, 10-yr window)147.9%
    ✓Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)P/E 22.4x (growth N/A)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR-8.6%
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    Inventory Growth vs Revenue GrowthInv: -3.6% vs Rev: -3.7%
    ✗LynchInventory growth < Revenue growth
    EPS Growth Direction$2.17 (2009) -> $9.89 (2025)
    ✓DremanPositive over recent years
    EPS CAGR9.9% CAGR over 16 years
    ✓Dreman> 5% annualized
    Positive Net Income Frequency17/17 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth-2.4%
    ✗Ackman>= 5%
    Positive EPS Growth Frequency3/5 years with positive EPS growth
    ✓AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR-8.6% CAGR over 5 years
    ✗Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trendgross margin 42.4% -> 48.5%, operating margin 5.0% -> 7.4%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR2.5%
    ✗SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR-8.6% over 5 years
    ✗Neff7%-20% annualized

Business & financials

Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

Company Profile

Industry: Beer & Liquor
SIC Sector: Food Products
Size: Mid Cap($2.3B)
Revenue: $2.0B-2.4% YoY
Net Income: $108.5M+81.7% YoY

Financial Snapshot

Operating Margin7.4%
Return on Equity12.8%
Debt / Equity0.00
Current Ratio1.65
EPS (Diluted)$9.89+95.5% 1y
Buybacks (1y)$202.4M
Buybacks (2y)$441.0M
Shares Retired7.0% / 10.8% 2y

Similar Companies

KOCOCA COLA CO
$427.0B
PEPPEPSICO INC
$198.2B
BUDAnheuser-Busch InBev SA/NV
$167.0B
DEODIAGEO PLC
$56.6B

Shareholder Return

Fiscal 2025

Retired 7.0% of shares last year, 10.8% over two.

Buybacks
$202.4M
Dividends
—

What drove EPS

A buyback raises earnings per share without the company earning more. This splits each year's change into the two.

FY22
365.0% = 362.2% + 0.6%
FY23
14.2% = 13.4% + 0.7%
FY24
−18.5% = −21.7% + 4.1%
FY25
95.5% = 81.7% + 7.6%
Earnings Fewer shares More shares

The two parts do not sum exactly to the total — the difference is the cross-term, plus preferred capital where the company has any. It is left visible rather than distributed into the other two.

Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

MetricTTM · 2026-09-26

2025-09-28 – 2026-09-26

Sources · derived quarter values

Derived from cumulative filings: revenue, net income, operating income, gross profit, ebit, pre tax income, operating cash flow, depreciation amortization, capex, buybacks.

Q3 FY 2026

2026-06-28 – 2026-09-26

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, depreciation amortization, capex, buybacks.

Q2 FY 2026

2026-03-29 – 2026-06-27

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, depreciation amortization, capex, buybacks.

Q1 FY 2026

2025-12-28 – 2026-03-28

Sources
FY 2025
Sources
  • 10-K · 2026-02-24
FY 2024
Sources
  • 10-K · 2025-02-25
FY 2023
Sources
  • 10-K · 2024-02-27
FY 2022
Sources
  • 10-K · 2023-02-22
FY 2021
Sources
  • 10-K · 2022-02-22
Market Cap$2.3Bcurrent------$2.3Best.$2.9Best.$4.3Best.$4.8Best.$5.2Best.
Revenue$1.9B↓4%$520.1M↓3%$568.3M↓3%$433.9M↓4%$2.0B↓2%$2.0B$2.0B↓4%$2.1B↑2%$2.1B
Operating Income-$96.4M↓179%$56.3M↓9%$70.8M↓14%-$190.5M↓664%$144.9M↑91%$76.0M↓24%$100.0M↑10%$90.8M↑1035%$8.0M
Net Income-$73.1M↓179%$43.2M↓6%$51.6M↓15%-$145.3M↓695%$108.5M↑82%$59.7M↓22%$76.3M↑13%$67.3M↑362%$14.6M
EPS (Diluted)--$4.21↓1%$4.96↓9%$-13.88↓743%$9.89↑95%$5.06↓19%$6.21↑14%$5.44↑365%$1.17
Gross Margin49.1%↑3%51.7%↑2%50.4%↑1%49.3%↑2%48.5%↑9%44.4%↑5%42.4%↑3%41.2%↑6%38.8%
Operating Margin-5.1%↓182%10.8%↓6%12.5%↓11%-43.9%↓690%7.4%↑95%3.8%↓24%5.0%↑15%4.3%↑1018%0.4%
ROE-9.9%↓198%———12.8%↑97%6.5%↓8%7.1%↑12%6.3%↑325%1.5%
Total Debt$0$0$0$0$1.1M↓61%$2.8M↑5%$2.7M↑86%$1.5M↓52%$3.1M
Shareholders' Equity$735.7M↓19%$735.7M↓19%$714.6M↓22%$682.6M↓24%$846.3M↓8%$916.2M↓15%$1.1B↑1%$1.1B↑9%$983.4M
Current Ratio1.13↓38%1.13↓38%1.05↓41%0.93↓46%1.65↓8%1.80↓20%2.25↑9%2.07↑53%1.35
Debt / Equity0.000.000.000.000.00↓58%0.00↑23%0.00↑84%0.00↓56%0.00
Operating Cash Flow$234.1M↓14%$76.6M↓25%$138.0M↑9%-$20.4M↓1154%$270.2M↑9%$248.9M↓6%$265.2M↑33%$199.9M↑255%$56.3M
Free Cash Flow$185.1M↓13%$68.3M↓24%$127.5M↑14%-$32.8M↓310%$215.6M↑25%$172.6M↓14%$201.1M↑84%$109.4M↑219%-$91.6M

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Beer & Liquor

SAM vs Peers — Financial Grading

Revenue$2.0BBottom 25%
Net Income$108.5MBottom 25%
ROE12.8%Bottom 25%
D/E0.00Top 25%
Op. Margin7.4%Bottom 25%
Curr. Ratio1.65Top 25%
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroskiDreman
COCA COLA COKO$427.0B$99.25$47.9B$13.1B40.7%1.3728.7%1.463/96/94/71/3F-Score 73/11
PEPSICO INCPEP$198.2B$145.44$93.9B$8.2B40.4%2.4112.2%0.854/96/93/71/3F-Score 56/11
Anheuser-Busch InBev SA/NVBUD$167.0B$84.81$59.3B$6.8B7.8%0.8426.0%0.721/91/93/71/3F-Score 72/11
DIAGEO PLCDEO$56.6B$101.59$28.0B$2.5B22.9%2.1415.5%1.631/94/92/71/3F-Score 45/11
Keurig Dr Pepper Inc.KDP$49.5B$36.34$16.6B$2.1B8.1%0.6321.5%0.642/92/92/71/3F-Score 62/11
AMBEV S.A.ABEV$42.5B$2.76$16.1B$2.8B17.6%0.0426.4%0.961/95/96/73/3F-Score 64/11
CONSTELLATION BRANDS, INC.STZ$24.6B$145.61$9.1B$1.7B20.9%1.2729.8%1.081/92/92/71/3F-Score 55/11
BROWN FORMAN CORPBF-B$14.1B$30.65$3.9B$715.0M17.8%0.6125.5%3.245/96/92/71/3F-Score 75/11